Clinical Trials Database
Actively Recruiting:
Trial: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Conditions: Malignant Pleural Mesothelioma
Trial: Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma; Pleural Mesothelioma
Trial: Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma; Metastatic Cancer
Trial: Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery
Conditions: Malignant Mesothelioma
Trial: An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Conditions: Mesothelioma
Last modified: March 19 2010.

Request more free information on treatment options, financial compensation,
exposure sites, coping & support, plus much more.